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Ethical Considerations of Ovarian and
Testicular Tissue Cryopreservation in
Pre-Pubertal Children Who Cannot Assent
Katarina Lee†
Introduction
In the last two decades, fertility preservation options have
become a part of medical treatment for individuals undergoing
gonadotoxic treatments, most typically as a result of oncology
therapy.1
However, the majority of studies and literature
surrounding these procedures have focused on adults who have the
ability to consent and pubertal children who have the ability to
assent. The ethical considerations of experimental pre-pubertal
fertility cryopreservation techniques have not been adequately
addressed. The purpose of this Article is to argue that while parents
and guardians normally have the best interests of their wards in
mind when they make medical decisions, pre-pubertal fertility
cryopreservation is ethically too problematic to permit parental or
guardian consent without the child’s assent. There are five parts to
this Article: Part I will provide a background of the different fertility
cryopreservation techniques available and their success rates; Part
II will explain the guidelines governing pediatric experimental
research; Part III will discuss informed consent and assent in the
pediatric medical context; Part IV will provide the ethical
arguments in opposition to pre-pubertal fertility cryopreservation
without assent; and Part V will address the counter-arguments
permitting pre-pubertal fertility cryopreservation without assent.
I.

Current Fertility Preservation Technologies

There are several different fertility preservation techniques
for those who are undergoing gonadotoxic treatments, including
† The author holds a B.A. in Philosophy from the University of Dallas, a M.A.
in Bioethics from New York University, and a J.D. with a concentration in Health
Law and Bioethics from the University of Minnesota Law School. The author is a
Clinical Ethics Fellow at Baylor College of Medicine’s Center for Medical Ethics and
Health Policy and an Adjunct Professor of Law at South Texas College of Law.
1. Anahad O’Connor, After Cancer, Fertility Is Often Within Reach, N.Y. TIMES:
WELL (Sept. 23, 2013, 4:03 PM), http://well.blogs.nytimes.com/2013/09/23/afterchildhood-cancer-fertility-is-within-reach-for-many/?mcubz=1.
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hormonal therapies, gonad shielding during treatments, and
creative surgical techniques to prevent damage to the gonads.2
These treatments are often less invasive than fertility
cryopreservation techniques and as a result are less ethically
controversial. Additionally, both male and female pubertal patients
may cryopreserve their mature gametes. Sperm from male pubertal
patients is either retrieved through ejaculation or when “ejaculation
is not possible,” sperm may be retrieved through
“electroejaculation, testicular biopsy, testicular sperm extraction, or
epididymal sperm aspiration.”3 Ova from female pubertal patients
are retrieved through a process of hormonally stimulating the
ovaries to produce ova that are then aspirated from the ovary.4
Patients may then cryopreserve their gametes independently while
others may choose to create embryos with their gametes;
afterwards, these embryos are cryopreserved.
Female patients have the additional option of cryopreserving
ovarian tissue, a procedure that is currently experimental.5
Ovarian tissue cryopreservation entails removing either “part of an
ovary or a whole ovary.”6 In partial ovarian tissue cryopreservation,
the ovarian cortex, or “the ovary’s outer layer,”7 is removed, then
sliced into small strips and cryopreserved.8 Eventually, these slices
are thawed and placed back into the woman’s body so that she can
conceive naturally.9 The benefit of cryopreserving ovarian tissue is
that “[m]ost oocytes are located within the primordial follicles in the
ovarian cortex; therefore, obtaining a small volume of cortical tissue
potentially enables cryopreservation of large numbers of oocytes.”10

2. Stephanie J. Lee et al., ASCO Recommendation on Fertility Preservation in
Cancer Patients: Guidelines Summary, 2 J. ONCOLOGY PRAC. 143, 143–44 (2006).
3. Am. Soc’y for Reprod. Med., Fertility Preservation and Reproduction in
Patients Facing Gonadotoxic Therapies: A Committee Opinion, 100 FERTILITY &
STERILITY 1224, 1226 (2013).
4. Tests and Procedures: In Vitro Fertilization (IVF), What You Can Expect,
MAYO CLINIC, http://www.mayoclinic.org/tests-procedures/in-vitro-fertilization/
basics/what-you-can-expect/prc-20018905 (last visited Oct. 23, 2017).
5. Am. Soc’y for Reprod. Med., Ovarian Tissue Cryopreservation: A Committee
Opinion, 101 FERTILITY & STERILITY 1237, 1237 (2014).
6. Fertility Preservation by Ovarian Tissue Banking (Ovarian Tissue Freezing),
CTR. FOR HUMAN REPROD., https://www.centerforhumanreprod.com/services/fertility
-preservation/ovarian-tissue-freezing/ (last updated Nov. 15, 2014).
7. Id.
8. Female Cancer, Cryopreservation, and Fertility, AM. SOC’Y FOR REPROD. MED.
(2014),
http://www.reproductivefacts.org/globalassets/rf/news-and-publications/
bookletsfact-sheets/english-fact-sheets-and-info-booklets/female_cancer_
cryopreservation_and_fertility_factsheet.pdf.
9. Id.
10. Am. Soc’y for Reprod. Med., supra note 5.
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There have been successful pregnancies that have resulted from the
re-transplantation of ovarian tissue,11 including one recent patient
who underwent the procedure prior to puberty. 12 If total ovarian
failure is anticipated, an entire ovary may be removed and
cryopreserved.13 Notably, whole ovary cryopreservation is not as
medically developed as partial ovarian tissue cryopreservation.
There have not been any successful pregnancies resulting from a
whole ovary being cryopreserved and then re-transplanted into the
female.14 There has been a successful pregnancy from a whole ovary
being donated to another woman15 and a successful pregnancy in
which a whole ovary was removed, tissue was then removed from
the ovary, and that tissue was then grafted to the woman’s
remaining ovary.16
The gametes of pre-pubertal patients cannot be retrieved
through ejaculation or ova retrieval.17 As a result, the only means
of fertility cryopreservation for female children is ovarian tissue
cryopreservation, which is identical to pubertal ovarian tissue
cryopreservation.18 The only option for male children is testicular
tissue cryopreservation, as they are unable to produce semen and
do not produce mature sperm.19 Pre-pubertal testicular tissue
contains stem cells that have the possibility of becoming mature
sperm.20 The idea is that the testicular tissue is either “reimplanted
11. Rob Stein, Freezing Ovaries Before Cancer Treatment May Preserve Fertility,
NPR (Oct. 7, 2015, 2:29 PM), http://www.npr.org/sections/healthshots/2015/
10/06/446324220/freezing-ovaries-before-cancer-treatment-may-preserve-fertility
(noting that Danish researchers found roughly one-third of participants who
underwent the procedure succeeded in having a child).
12. Meera Senthilingam, Woman Is First to Have Baby with Ovaries Frozen in
Childhood, CNN (Dec. 16, 2016, 3:40 PM), www.cnn.com/2016/12/15/health/firstbirth-from-frozen-ovarian-tissue/index.html.
13. Am. Soc’y for Reprod. Med., supra note 5, at 1238.
14. Freezing and Storing Eggs, HUMAN FERTILISATION & EMBRYOLOGY AUTH.,
http://hfeaarchive.uksouth.cloudapp.azure.com/www.hfea.gov.uk/46.html
(last
accessed Oct. 23, 2017).
15. James Randerson, Woman to Give Birth After First Ovary Transplant
Pregnancy, THE GUARDIAN (Nov. 9, 2008, 7:52 AM), http://www.theguardian.com/
science/2008/nov/09/health; Sherman J. Silber, Gedis Grudzinskas & Roger G.
Gosden, Successful Pregnancy After Microsurgical Transplantation of an Intact
Ovary, 359 NEW ENG. J. MED. 2617, 2617 (2008).
16. Baby Born from Ovary Frozen in Mother’s Childhood, BBC NEWS, (June 10,
2015), http://www.bbc.com/news/health-33063838.
17. Christine Wyns et al., Options for Fertility Preservation in Prepubertal Boys,
16 HUMAN REPROD. UPDATE 312, 315 (2010).
18. Am. Soc’y for Reprod. Med., supra note 5.
19. Wyns, supra note 17, at 312–315.
20. Fertility Preservation Program, CHILDREN’S HOSP. OF PHILA.,
http://www.chop.edu/services/fertility-preservation-program#.VkYOb4RDm51 (last
visited Nov. 21, 2017).
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as is or matured” prior to transplantation back into the grown and
healthy child.21 There has not been any proven success in humans,
but animal studies have shown that testicular tissue can feasibly be
removed and cryopreserved.22 The Fertility Preservation Program
at The Children’s Hospital of Philadelphia (CHOP) is one of the
most advanced and widely publicized centers in the United States
providing these experimental treatments.23
II. Experimental Treatment in Pediatrics
These fertility cryopreservation techniques are experimental,
meaning that children undergoing them should be protected by
standard human research protocols for pediatrics. As a result,
clinicians have developed protocols in order to comply with ethical
standards in pediatric clinical trials.24 In 2010, CHOP published its
protocol for testicular tissue cryopreservation.25 Similarly, in 2012,
the University of Pennsylvania, in conjunction with CHOP, the
Oncofertility Consortium, and the National Physicians Cooperative,
published a protocol for pre-pubertal ovarian tissue
cryopreservation.26 Institutional Review Board (IRB) approval for
pre-pubertal ovarian tissue cryopreservation was originally granted
in April 2007 at the Hospital of the University of Pennsylvania
(HUP) and in May 2009 at CHOP.27
Generally, research that is either funded by federal dollars or
performed by certain government agencies or individuals is subject

21. Id.
22. Id.; Honor Whiteman, Deep-Freezing Testicular Tissue Produces Healthy
Baby
Mice,
MED.
NEWS
TODAY
(July
2,
2014,
8:00
AM),
http://www.medicalnewstoday.com/articles/279093.php.
23. Fertility Preservation Program, supra note 20. Note that many premier
hospitals have begun offering fertility preservation programs in recent years.
24. Jordan Reese, Penn Researchers Find Reproductive Germ Cells Survive and
Thrive in Transplants, Even Among Species, U. PENN NEWS (Dec. 14, 2009),
http://www.upenn.edu/pennnews/news/penn-researchers-find-reproductive-germcells-survive-and-thrive-transplants-even-among-species.
25. J.P. Ginsberg et al., An Experimental Protocol for Fertility Preservation in
Prepubertal Boys Recently Diagnosed with Cancer: A Report of Acceptability and
Safety, 25 HUMAN REPROD. 37, 38 (2010). See PENN CTR. FOR BIOETHICS, THE PENN
CENTER GUIDE IN BIOETHICS 335–36 (Vardit Ravitsky, Autumn Fiester & Arthur L.
Caplan eds., 2009) (“If children cannot ejaculate or are too young, then testicular
biopsy for sperm extraction or biopsy to use as germ cell repository can be done under
IRB experimental conditions.”).
26. Clarisa R. Gracia et al., Ovarian Tissue Cryopreservation for Fertility
Preservation in Cancer Patients: Successful Establishment and Feasibility of a
Multidisciplinary Collaboration, 29 J. ASSISTED REPROD. & GENETICS 495, 495
(2012).
27. Id. at 496.
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to the Common Rule.28 The Common Rule, codified in the Code of
Federal Regulations, requires human subjects research, including
research conducted on children, to abide by specific guidelines and
ethical standards. Non-governmental institutions “that engage in
human subject research that is conducted or supported by any U.S.
federal department or agency that has adopted the Common Rule
are required to”29 adopt the Federalwide Assurance (FWA). This
means, “an institution commits to HHS [Health and Human
Services] that it will comply with the requirements in the HHS
Protection of Human Subjects regulations at 45 CFR part 46 [The
Common Rule].”30 A pre-requisite of receiving FWA designation is
that the institution is required to designate an IRB to perform
“ethical review of proposed research.”31
The University of
Pennsylvania32 and CHOP33 have adopted the FWA; as a result,
research conducted at these institutions is required to follow the
federal guidelines.
Using these federal guidelines, IRBs are to analyze pediatric
experimental procedures under the following four categories: (1)
“[r]esearch not involving greater than minimal risk,”34 (2)
“[r]esearch involving greater than minimal risk but presenting the
prospect of direct benefit to the individual subjects,”35 (3) “[r]esearch
involving greater than minimal risk and no prospect of direct
benefit to the individual subjects, but likely to yield generalizable
28. 45 C.F.R. § 46.101 (2016); Federal Policy for the Protection of Human Subjects
(‘Common Rule’), U.S. DEP’T. OF HEALTH & HUMAN SERVS.: OFFICE OF HUMAN
RESEARCH PROTECTIONS, http://www.hhs.gov/ohrp/humansubjects/commonrule/
index.html (last visited Nov. 8, 2017); Stanley G. Korenman, TEACHING THE
RESPONSIBLE CONDUCT OF RESEARCH IN HUMANS (RCRH) ch. 3 (2006),
https://ori.hhs.gov/education/products/ucla/chapter2/page04b.htm (last accessed
Nov. 8, 2017).
29. Jennifer S. Geetter & James W. Kim, OHRP Revises Federalwide Assurance,
NAT’L L. REV. (July 14, 2011), http://www.natlawreview.com/article/ohrp-revisesfederalwide-assurance.
30. Federalwide Assurances (FWAs), U.S. DEP’T OF HEALTH & HUMAN SERVS.,
http://www.hhs.gov/ohrp/assurances/assurances/index.html (last visited Sept. 23,
2017) (alteration in original).
31. OFFICE FOR HUMAN RESEARCH PROTS., U.S. DEP’T OF HEALTH & HUMAN
SERVS., IRBS AND ASSURANCES, https://www.hhs.gov/ohrp/irbs-and-assurances.html
(last visited Oct. 8, 2017).
32. Assurances, U PENN THE INSTITUTIONAL REVIEW BD., http://www.upenn.edu/
IRB/mission-institutional-review-board-irb/assurances (last visited Nov. 22, 2017)
(hereinafter IRB GUIDEBOOK).
33. Federalwide Assurance (FWA): Compliance with Federal Regulatory
Requirements and Guidelines, CHILDREN’S HOSP. OF PHILA. RESEARCH INST.,
https://irb.research.chop.edu/federalwide-assurance-fwa# (last visited Nov. 22,
2017).
34. 45 C.F.R. § 46.404 (2016).
35. § 46.405.
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knowledge about the subject’s disorder or condition,”36 and (4)
“[r]esearch [that is] not otherwise approvable which presents an
opportunity to understand, prevent, or alleviate a serious problem
affecting the health or welfare of children.”37 Minimal risk “means
that the probability and magnitude of harm or discomfort
anticipated in the research are not greater in and of themselves
than those ordinarily encountered in daily life or during the
performance of routine physical or psychological examinations or
tests.”38 The Institute of Medicine (IOM) has defined greater than
minimal risk to be “a slight increase in the potential for harms or
discomfort beyond minimal risk.”39 Additionally, IOM has defined
direct benefit as “a tangible positive outcome,” for example, “cure of
disease, relief of pain, and increased mobility.”40
In all four categories, IRBs are required to make sure
“[a]dequate provisions are made for soliciting the assent of the
children and permission of their parents or guardians.”41
Additionally, for research in Category 2, the following two
requirements are needed: “(a) [t]he risk is justified by the
anticipated benefit to the subjects; [and] (b) [t]he relation of the
anticipated benefit to the risk is at least as favorable to the subjects
as that presented by available alternative approaches.”42 For
research in Category 3, the following are required:
(a) [t]he risk represents a minor increase over minimal risk;
(b) [t]he intervention or procedure presents experiences to
subjects that are reasonably commensurate with those
inherent in their actual or expected medical . . . situations;
[and]
(c) [t]he intervention or procedure is likely to yield
generalizable knowledge about the subjects’ disorder or
36. § 46.406.
37. § 46.407; ROBIN LEVIN PENSLAR, PROTECTING HUMAN RESEARCH SUBJECTS:
INSTITUTIONAL REVIEW BOARD GUIDEBOOK ch. 6, 19–21 (2nd ed. 1993); Michelle
Roth-Cline et al., Ethical Considerations in Conducting Pediatric Research, in
PEDIATRIC CLINICAL PHARMACOLOGY (Hannsjörg W. Seberth, Anders Rane &
Matthias Schwab eds. 2011) 219, 225–30.
38. § 46.102(i).
39. Paul Litton, Non-Beneficial Pediatric Research and the Best Interests
Standard: A Legal and Ethical Reconciliation, 8 YALE HEALTH POL’Y ETHICS 359,
377 (2008) (quoting COMM. ON CLINICAL RESEARCH INVOLVING CHILDREN, INST. OF
MED., THE ETHICAL CONDUCT OF CLINICAL RESEARCH INVOLVING CHILDREN 17
(Marilyn J. Field & Richard E. Berman eds., 2004)).
40. COMM. ON CLINICAL RESEARCH INVOLVING CHILDREN, INST. OF MED., THE
ETHICAL CONDUCT OF CLINICAL RESEARCH INVOLVING CHILDREN 132 (Marilyn J.
Field & Richard E. Berman eds., 2004) [hereinafter CLINICAL RESEARCH INVOLVING
CHILDREN].
41. § 46.404–07.
42. § 46.405 (alteration in original).
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Lastly, for research in Category 4, the IRB must “find[] that
the research presents a reasonable opportunity to further the
understanding, prevention, or alleviation of a serious problem
affecting the health or welfare of children” and the Secretary, after
significant review, finds the research permissible.44
III. Informed Consent and Assent in Pediatric Patients
Informed consent in pediatric patients can create significant
legal and ethical concerns. Parents and guardians are legally able
to consent and make decisions for their wards provided these
medical decisions are in the best interests of the child.45 Under the
legal doctrine of parens patriae, the state has the authority to take
action to protect children if a parent or guardian “demonstrably
act[s] contrary to [the best] interests of the child.”46 As Professor
Anne Tamar-Mattis states:
The basis for parental control over the medical decisions for
treatment of children is two-fold. It arises out of both the
concept of a constitutional right to family privacy and the legal
presumption that parents are best situated to make good
decisions because “natural bonds of affection lead parents to act
in the best interests of their children.”47

Parents have been given significant deference to make medical
decisions for their children as a result of the legal and social
upholding of autonomous parenting.48 However, disagreements do
43. § 46.406.
44. § 46.407.
45. Jennifer L. Rosato, Using Bioethics Discourse to Determine When Parents
Should Make Health Care Decisions for Their Children: Is Deference Justified?, 73
TEMP. L. REV. 1, 7–8 (2000); Mary Koll, Growth, Interrupted: Nontherapeutic Growth
Attenuation, Parental Medical Decision Making, and the Profoundly
Developmentally Disabled Child’s Right to Bodily Integrity, 2010 U. ILL. L. REV. 225,
243 (2010).
46. J. Steven Svoboda, Robert S. Van Howe & James G. Dwyer, Informed
Consent for Neonatal Circumcision: An Ethical and Legal Conundrum, 17 J.
CONTEMP. HEALTH L. & POL’Y 61, 84 (2000).
47. Anne Tamar-Mattis, Exceptions to the Rule: Curing the Law’s Failure to
Protect Intersex Infants, 21 BERKELEY J. GENDER L. & JUST. 59, 79 (2006) (quoting
Parham v. J. R., 442 U.S. 584, 602 (1979)). Opinions differ regarding the use of the
best interests standard in pediatric experimental research. See Doriane Lambelet
Coleman, The Legal Ethics of Pediatric Research, 57 DUKE L. J. 517, 609–10 (2007)
(explaining how a balance between child protection and parents’ consent is the right
approach); Seema Shah, Does Research with Children Violate the Best Interests
Standard? An Empirical and Conceptual Analysis, 8 NW. J. L. & SOC. POL’Y 121,
165–66 (2013) (arguing that a child’s interest should not be absolute, but rather that
the value of research and the public good should also matter).
48. Lee Black, Limiting Parents’ Rights in Medical Decision Making, 8 AMA J.
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arise in the medical treatment of children. There have been several
legal actions where the religious beliefs of a parent have come into
conflict with medical decision making of a child.49 Generally,
medical practitioners are obligated to provide treatment to pediatric
patients if the treatment would reverse a life-threatening condition
regardless of parental or guardian disagreement.50 This longstanding concept is derived from the Supreme Court decision in
Prince v. Massachusetts, when the Court concluded, “[p]arents may
be free to become martyrs themselves. But it does not follow they
are free, in identical circumstances, to make martyrs of their
children before they have reached the age of full and legal discretion
when they can make that choice for themselves.”51 Considering this
legal framework, the American Academy of Pediatrics (AAP) has
created guidelines that assist in obtaining informed consent from
parents as well as assent from children; the AAP states: (1)
“[p]ractitioners should seek the informed permission of parents
before medical interventions (except in emergencies when parents
cannot be contacted)” and (2) “[d]ecision-making involving the
health care of older children and adolescents should include, to the
greatest extent feasible, the assent of the patient as well as the
participation of the parents and the physician.”52 As was noted in
the federal guidelines, child assent should be solicited, but is not
always legally required; as a result, it is usually left to IRB or ethics
committee discretion.53 Assent is defined as “a child’s affirmative
agreement to participate in research.”54 Notably, there is no specific
age at which a child can assent; however, in practice, assent is
sought from children above the age of six or seven.55 Instead,
determining the capacity to assent is analyzed by a variety of

ETHICS 676, 676 (2006); Koll, supra note 45, at 245–246 (discussing child organ
donation and sterilization).
49. Black, supra note 48, at 676–677; Svoboda, supra note 46, at 84–88.
50. Danielle Chaet, The AMA Code of Medical Ethics’ Opinions Relevant to
Patient- and Family-Centered Care, 18 AMA J. OF ETHICS 45, 45–46 (2016).
51. 321 U.S. 158, 170 (1944).
52. Comm. on Bioethics, Am. Acad. of Pediatrics, Informed Consent, Parental
Permission, and Assent in Pediatric Practice, 95 PEDIATRICS 314, 315 (1995)
(emphasis omitted) [hereinafter Am. Acad. of Pediatrics].
53. CLINICAL RESEARCH INVOLVING CHILDREN, supra note 40, at 194–195
(providing examples of how IRB has practiced discretion); NAT’L INST. OF HEALTH,
NAT’L CANCER INST., CHILDREN’S ASSENT (June 22, 2016), https://www.cancer.gov/
about-cancer/treatment/clinical-trials/patient-safety/childrens-assent.
54. CLINICAL RESEARCH INVOLVING CHILDREN, supra note 40, at 157–158.
55. Id. at 156.
OF
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factors such as: psychological capacity, emancipation status, and
whether the child is a “mature minor.”56
The AAP requires that medical practitioners receive assent
from capable pediatric patients by: (1) helping the pediatric
patients understand their condition, (2) explaining the tests and
treatments they will undergo, (3) making an assessment of how
much the pediatric patient is understanding, and (4) “[s]oliciting an
expression of the patient’s willingness to accept the proposed
care.”57 Furthermore, in regard to the expression of assent, the
medical practitioner is required to weigh the child’s assent
“seriously,” when considering appropriate medical care.58 In human
subjects research there is disagreement as to whether child assent
is always required.59 Notably, Ravitsky et al., argue the following
in regard to assent in ovarian and testicular tissue
cryopreservation,
Child assent and parental consent should always be sought. If
the child is too young to give assent, no procedure involving
more than minimal risk and not for their proven benefit should
be permitted. The consent should cover the possible use of the
reproductive tissue, the duration of storage, and the disposal of
the tissues in event of mental incapacitation or death.60

Given the federal and medical framework within which IRBs
are to analyze the ethical permissibility of experimental fertility
cryopreservation techniques, one can begin discussing the ethical
arguments in favor of and opposed to testicular and ovarian tissue
cryopreservation in pre-pubertal children who cannot assent.61
IV. Arguments in Opposition to Pre-Pubertal Ovarian and
Testicular Tissue Cryopreservation Without Assent
This section of the Article will address the four main
arguments in opposition to pre-pubertal ovarian and testicular
tissue cryopreservation with children who cannot assent: (a) that
these procedures are too medically risky, (b) that there is an
impermissible conflict of interest in allowing parents and guardians
56. Id. at 324–25 (explaining that the mature minor rule means a child is
“sufficiently mature to make (certain) health care decisions”); 45 C.F.R. § 46.408(a)
(2016); IRB GUIDEBOOK, supra note 32, at 6–22.
57. Am. Acad. of Pediatrics, supra note 51, at 315.
58. Id. at 315–16.
59. D.S. Wendler, Assent in Paediatric Research: Theoretical and Practical
Considerations, 32 J. MED. ETHICS 229, 230 (2006).
60. PENN CTR. FOR BIOETHICS, supra note 24, at 336.
61. Note, for the few children who will reach puberty prior to the age of assent,
parents and guardians should also be prohibited from cryopreserving their gametic
material, as most of the arguments in this Article remain persuasive.
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to consent, (c) that these procedures create secondary ethical
problems through issues of control over gametic material, and (c)
that given the federal guidelines and the lack of proven success, it
is questionable whether this research should be conducted
altogether on children.
a. Medical Risks
One of the major ethical concerns with childhood ovarian and
testicular tissue cryopreservation is the issue of subjecting
individuals who cannot assent or consent to non-medically
necessary procedures. As will be discussed later, it is foreseeable
that individuals will differ on determining the medical riskiness of
ovarian and testicular tissue cryopreservation. However, any
additional medical procedure has potential medical consequences,62
and each additional procedure performed on a child will increase
their medical risks.63 There are several different types of medical
risk associated with this form of fertility preservation:
(i)
procedural risk, (ii) reproductive organ and gametic risk, (iii) retransplantation risk, and (iv) psychological risk.
i.

Procedural Risk

Ovarian tissue is procured through laparoscopy surgery,64
while testicular tissue is procured through removal of a testicle65 or
through a biopsy.66 Testicular and ovarian tissue can either be
procured simultaneously as the child is undergoing an unrelated
medical procedure or the procedure can occur independently.67
Children are required to undergo general anesthesia in order that
the surgery can be performed to remove the tissue.68 The argument
62. Heidi Stevens, What Does the Future Hold for Kids with Cancer?, STAR TRIB.
(June 7, 2012, 8:10 AM), http://www.startribune.com/what-does-the-future-hold-forkids-with-cancer/157559905/ (discussing fertility preservation for young children
diagnosed with cancer).
63. Id.
64. Marie-Madeleine Dolmans et al., A Review of 15 Years of Ovarian Tissue
Bank Activities, 30 J. ASSISTED REPROD. & GENETICS 305, 312 (2013).
65. U. PITTSBURGH, MANUAL OF OPERATIONS: TESTICULAR TISSUE
CRYOPRESERVATION 5 (Sept. 2014), http://oncofertility.northwestern.edu/sites/
oncofertility/files/TTC_Manual_of_Operations.pdf.
66. CHILDREN’S HOSP. OF PHILA., supra note 20.
67. Lindsey Tanner, Kids with Cancer Get Futuristic Fertility Chance;
Experimental Tissue-Freezing Even for Babies, U.S NEWS & WORLD REP. (Sep. 28,
2017, 9:28 AM), http://health.usnews.com/health-news/news/articles/2015/08/11/
kids-with-cancer-get-futuristic-chance-at-saving-fertility.
68. Mark F. H. Brougham & W. Hamish B. Wallace, Male Infertility Following
Childhood Cancer: Special Considerations for Fertility Preservation in Children, in
FERTILITY PRESERVATION IN MALE CANCER PATIENTS 164 (John P. Mulhall et al.
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in favor of a simultaneous procedure is that the child does not need
to undergo an additional anesthesia. This is especially important
in young children, as there is significant concern about the effects
of anesthesia on their brains.69 Studies have shown “an association
between learning problems and multiple exposures to anesthesia
early in life—though not single exposures.”70 However, there are
also concerns about keeping a child anesthetized for a lengthier
period of time to complete the additional procedure, as there is some
evidence that suggests spending more time under anesthesia can
negatively impact recovery.71 Usually, the risk of lengthier
anesthesia is less than multiple anesthesias.72 Notably, there has
been at least one death reported due to an anesthesia complication
during ovarian tissue cryopreservation.73 In addition to anesthetic
concerns, ovarian tissue retrieval can cause “discomfort, pain,
bleeding from cicatrices,”74 and urinary tract infection.75 Another
medical concern is whether ovarian or testicular tissue
cryopreservation may compromise medically necessary care for the
child, for example, if the child were to contract an infection and then
not be eligible to undergo their medically necessary oncology
treatments because of a weakened immune system.
ii. Reproductive Organ and Gametic
Tissue Risk
There is both a risk to the tissue that is cryopreserved and a
risk of damaging reproductive organs or material that are not
surgically removed. There is a concern that testicular tissue
eds., 2013).
69. Denise Grady, Researchers Warn on Anesthesia, Unsure of Risk to Children,
N. Y. TIMES (Feb. 25, 2015), http://www.nytimes.com/2015/02/26/health/researcherscall-for-more-study-of-anesthesia-risks-to-young-children.html; Tara Haelle, More
Evidence That General Anesthesia May Affect Young Brains, HEALTHDAY NEWS,
https://consumer.healthday.com/cognitive-health-information-26/brain-health-news
-80/more-evidence-that-general-anesthesia-may-affect-young-brains-700124.html
(last updated June 8, 2015).
70. Grady, supra note 68.
71. Catherine Sharoky, Time Spent Under Anesthesia Could Up Risk, MED.
ONLINE (July 20, 2005), http://www.medicineonline.com/news/12/1129/Time-spentunder-anesthesia-could-up-risk.html; Robert A. Yoho, Deborah A. O’Neil & Jeremy
J. Romaine, Duration of General Anesthesia and Surgical Outcome, http://cite
seerx.ist.psu.edu/viewdoc/download?doi=10.1.1.501.7332&rep=rep1&type=pdf (last
accessed Oct. 23, 2017).
72. Sharoky, supra note 71.
73. R. Imbert et al., Safety and Usefulness of Cryopreservation of Ovarian Tissue
to Preserve Fertility: A 12-Year Retrospective Analysis, 29 HUM. REPROD. 1931, 1938
(2014).
74. Id.
75. Dolmans, supra note 64, at 310.
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retrieval may cause trauma to the testicle.76 Similarly, it is
foreseeable that there could be trauma to the ovary (a concern with
ova retrieval).77 In one study reporting on whole ovary removal,
twenty-seven percent of individuals reported complications due to
the procedure, including the need to have “additional surgeries for
cutaneous infections or bladder lesions.”78
Furthermore,
cryopreservation can damage gametes through the process of being
cryopreserved and then thawed.79 Additionally, cryopreserving a
full ovary can “fracture . . . the ovarian pedicle, preventing
successful vascular transplantation; fracture of the surface of the
ovary as a whole, which then provides an interface for ice crystal
formation; inconsistent permeation of the cryoprotectant; and
potential for ice crystal formation in the ovarian pedicle or ovary
during warming.”80
iii. Re-transplantation Risk
Another major concern about the reimplantation of
cryopreserved gametic tissue is the potentiality of reintroducing
cancerous cells into the patient.81 This is a concern for both
testicular82 and ovarian83 tissue cryopreservation. Typically,
testicular and ovarian tissue cryopreservation is sought prior to
gonadotoxic treatments to prevent damage to the tissue, but as a
result, there may be cancerous tissue removed simultaneously with
the gametic tissue.84 The type of cancer that the patient suffers
from may impact whether there is the possibility of retransplanting cancerous cells from their gametic tissue.85 Tissue
taken from individuals who suffer from blood-borne cancers, such
76. G. Bahadur, R. Chatterjee & D. Ralph, Testicular Tissue Cryopreservation in
Boys. Ethical and Legal Issues, 15 HUM. REPROD. 1416, 1419 (2000).
77. COMM. ON ASSESSING MED. RISK, ASSESSING THE MEDICAL RISKS OF HUMAN
OOCYTE DONATION FOR STEM CELL RESEARCH: WORKSHOP REPORT 32 (Linda
Giudice, Eileen Santa & Robert Pool eds., 2007), http://www.nap.edu/
download.php?record_id=11832# (describing the connection between the surgical
process and potential complications).
78. Imbert, supra note 73, at 1938.
79. Batuhan Özmen & Safaa Al-Hassani, Techniques for Ovarian Tissue, Whole
Ovary, Oocyte and Embryo Cryopreservation, 11 J. REPROD. & INFERTILITY 3, 4–6
(2010); Dolmans, supra note 64, at 311; Jason Pacchiarotti et al., Developing a
Clinical-Grade Cryopreservation Protocol for Human Testicular Tissue and Cells,
2014 BIOMED RESEARCH INT’L 1, 4 (2013).
80. Am. Soc’y for Reprod. Med., supra note 5, at 1238.
81. Id.
82. Pacchiarotti, supra note 79, at 9.
83. BBC NEWS, supra note 16.
84. Bahadur, supra note 76, at 1418; Dolmans, supra note 64, at 312.
85. Bahadur, supra note 76, at 1418; Dolmans, supra note 64, at 312.
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as leukemia, have tested positive for cancerous cells.86 In one study,
tissue taken from breast cancer patients did not indicate cancerous
cells, but the researchers cautioned that more screening was
necessary.87 Another study concluded that the possibility of
reintroducing cancer was high in leukemia patients, moderate for
gastrointestinal cancer patients, and low for Hodgkin’s and NonHodgkin’s Lymphoma, breast cancer, gynecological cancers, and
sarcomas of the bone and connective tissue.88
iv. Psychological Risk
In addition to the physiological risks discussed above, it is
worth noting the potential psychological impact ovarian and
testicular tissue cryopreservation may have. This is a risk that can
affect the child, the parents, and guardians who consent to the
procedure.89 There are three main concerns: (1) individuals will
experience great emotional loss if the procedures do not work; (2)
individuals may build up unrealistic faith and reliance upon the
idea of using this gametic material in the future; and (3) if there are
complications, the negative emotional impact this may have on the
parents or guardians who consented to the procedure. Parents and
guardians as well as the child are at risk for experiencing loss if
these procedures are unsuccessful—the loss of potential geneticallyrelated children and grandchildren. Furthermore, reliance upon
frozen gametic tissue may impact choices and decisions cancer
survivors make in their future, such as delaying procreation.
Lastly, if there are negative complications, or if these procedures
impact a child’s medically-necessary treatment, it is foreseeable
that parents and guardians may experience guilt or remorse.
However, clinical psychologist Dan Shapiro of the Humanities
Department at Pennsylvania State University, College of Medicine,
disagrees with many of these psychological concerns. Shapiro
argues that “[g]iven what we know about the psychological
challenges of infertility, which is enormously stressful—about as
stressful as having a chronic pain condition—and the exciting
promise of ovarian cryopreservation techniques, I think parents of

86. See Dolmans, supra note 64, at 312; see also Bahadur, supra note 76, at 1418
(discussing the risk of such transmission and trial evidence from mice).
87. Dolmans, supra note 64, at 312.
88. Mikkel Rosendahl, Tine Greve & Claus Yding Andersen, The Safety of
Transplanting Cryopreserved Ovarian Tissue in Cancer Patients: A Review of the
Literature, 30 J. ASSISTED REPROD. & GENETICS 11, 11 (2013).
89. Stevens, supra note 62.
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children facing cancer treatments would be mistaken not to try
this.”90
From a utilitarian ethical analysis, conducting these
procedures in pre-pubertal children who cannot assent to these
risks is ethically impermissible. Parents and guardians should not
risk the life and health of their children for the mere possibility that
their children may be able to use this tissue in the future.
Moreover, as was mentioned earlier in this Article, gonadotoxic
treatments do not necessitate infertility. The most significant
counter-argument to the medical-risk concern is that researchers
and medical practitioners could mitigate some of the risk by
following a criterion to determine which patients are the best
candidates for tissue cryopreservation.91 While selection criteria
will limit who these procedures will be offered to, it does not address
the fact that parents and guardians should not be risking the health
and life of their children for a medically unnecessary procedure. If
a child can and is willing to assent to this procedure, then medical
practitioners should engage in a conversation about the risks and
potential outcomes, but parents and guardians should not be
permitted to subject their already-compromised child to additional
medical risk, even at the risk of infertility. Potential procreative
capability does not outweigh the health and life of the child.
b. Conflict of Interest
One of the major ethical concerns about cryopreservation is
whether parents and guardians who consent to their pre-pubertal
children undergoing these procedures have a conflict of interest.
The conflict argument stems from the concern that parents, by
cryopreserving their children’s ovarian or testicular tissue, are
either (1) acting in their self-interest in that they want geneticallyrelated grandchildren, or (2) that they are imposing their preference
of procreation on their children. Regarding the first concern, the
90. Id.
91. See W. Hamish B. Wallace et al., Fertility Preservation for Girls and Young
Women with Cancer: Population-Based Validation of Criteria for Ovarian Tissue
Cryopreservation, 15 LANCET ONCOLOGY 1129, 1130 (2014). In 2014, the University
of Edinburgh set forth a criterion called the “Edinburgh Selection Criteria” to
determine which female patients should be eligible for ovarian tissue
cryopreservation. The following were used as selection criteria: (1) the patient was
younger than 35 years; (2) had not received chemotherapy or radiotherapy if aged 15
or older, but mild, non-gonadotoxic chemotherapy was acceptable in female patients
under 15; (3) a likely chance of living for five years; (4) a greater than 50% risk of
developing premature ovarian insufficiency; (5) informed consent and assent (if
possible); (6) negative HIV, syphilis, and hepatitis B tests; and (7) the patient was
not pregnant and had no existing children. Id.
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parent or guardian may have a great desire to have grandchildren
and therefore may be cryopreserving their child’s ovarian or
testicular tissue so that they will be able to fulfill that desire to
become a grandparent. The second concern is that parents or
guardians will impose a sense of duty and pressure upon their child
to eventually procreate in the future if they cryopreserve their
ovarian or testicular tissue.
There are no persuasive counter-arguments to the concern
that parents or guardians may be acting in their own self-interest,
as it is nearly impossible to determine whether the parent or
guardian simply wants to provide an option for future fertility for
their child or if they are acting based upon their desire to become a
grandparent. It is arguable that parents and guardians may not
even realize that they are acting in their own self-interest, as they
are too emotionally invested in their child’s fertility. Notably, in the
testimonies of parents who are a part of the experimental work
being done at the University of Pennsylvania, many of the parents
reiterated that they wanted to be grandparents.92 Moreover,
medical staff state that it is part of their job to “let [patients] know
why [ovarian and testicular tissue cryopreservation] is important,
and to . . . set the scene,” even when the children stated that they
did not know if they wanted to have kids.93
Furthermore, allowing parents and guardians to consent
without a child’s assent imposes certain values about procreation
on children, when many individuals do not wish to procreate or may
have different values regarding how they wish to build their
families. Quinn et al., argued that these concerns are not justified
because a child’s values are already impacted by their upbringing,
including the decision to have children, and that a child may feel
pressure regardless of the situation to abide by their parent’s
wishes.94 However, these counterarguments are unconvincing, as
these children will eventually have to make decisions whether to
implant, destroy, or donate their cryopreserved ovarian or
testicular tissue, a situation they may not have desired to be in.
Moreover, they may feel even more compelled to procreate because
of the burden their families underwent to cryopreserve their
92. See Fertility Options for Young Female Cancer Patients, CHILDREN’S HOSP.
PHILA. (Oct. 7, 2014), http://www.chop.edu/video/fertility-options-young-femalecancer-patients#.VkoyooRDm50; see also Fertility Preservation for Boys Treated for
Cancer, CHILDREN’S HOSP. OF PHILA. (July 14, 2014), http://www.chop.edu/video/
fertility-preservation-boys-treated-cancer#.VkoyJIRDm50.
93. Fertility Preservation for Boys Treated for Cancer, supra note 92.
94. Gwendolyn P. Quinn et al., Preserving the Right to Future Children: An
Ethical Case Analysis, 12 AM. J. BIOETHICS 38, 39 (2012).
OF
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ovarian or testicular tissue. I do not intend to argue that procuring
a child’s assent will alleviate all of these conflicting concerns, as
parents or guardians may still pressure their children to assent, but
arguably, based upon the AAP’s ethical guidelines stated earlier in
this Article, assent will provide a better opportunity that a child’s
wishes will be abided by.
c. Decision-Making Concerns Regarding Cryopreserved
Ovarian and Testicular Tissue
Another ethical concern is the issue of “control” of the ovarian
or testicular tissue. The control issue has several components: (1)
control over the tissue while the child is minor, (2) disposition of
tissue, (3) claims to the tissue, and (4) addressing conflict. In regard
to the first concern, if a child has the ability to assent, they would
have the ability to partake in the decision-making process regarding
their gametic tissue. However, if the child cannot assent, who
should have the ability to make decisions over the gametic
material? Will the material be cryopreserved until the child can
assent? Additionally, it is unclear if the tissue would be retransplanted when the child is healthy, when they can assent, or
when they have reached majority. Regarding the second concern,
as was mentioned above, Ravitsky et al. argue that the tissue needs
to be destroyed if the child dies or is incapacitated.95 Not only is
permitting a parent or guardian to consent to destroying another
independent individual’s gametic material ethically problematic, it
is foreseeable that a child may want their tissue donated and not
destroyed.
There is also a potential concern that a parent or guardian
may have a claim to the gametic material if the child dies. There
are already controversies that occur when parents of deceased
children stake a claim to the gametic material of their children.96
Lastly, if the child cannot assent, it is unclear how conflict will be
dealt with. The Office of the Human Research Protection Program
states that when there is a conflict, a child should not be part of a
study until the conflict is resolved.97 But what happens if parents
95. PENN. CTR. FOR BIOETHICS, supra note 25, at 336.
96. See Hall v. Fertility Inst. of New Orleans, 94-1135 (La. Ct. App. 1994) 647
So. 2d 1348; see also Jessica Elgot, Mother Loses Bid to Use Dead Daughter’s Frozen
Eggs to Give Birth to Grandchild, THE GUARDIAN (June 15, 2015, 11:59 AM),
http://www.theguardian.com/society/2015/jun/15/mother-loses-bid-to-use-deaddaughters-frozen-eggs-to-give-birth-to-grandchild; Yoram Yarkoni, Fallen Soldier’s
Sperm at Center of Battle, YNET (March 25, 2015, 10:54 PM),
http://www.ynetnews.com/articles/0,7340,L-4640932,00.html.
97. See U.C.L.A.: OFFICE OF HUM. RESEARCH PROT. PROGRAM, Guidance and
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and guardians do not agree after the tissue is cryopreserved? The
current solution for conflict surrounding gametic material has been
litigation.
A simpler solution would be to conduct these
experimental procedures only on children who can assent.
d. Should We Be Doing This Research?
Fundamentally, underlying all of the opposition arguments to
pre-pubertal ovarian and testicular tissue cryopreservation without
a child’s assent is the question of whether this type of experimental
research is permissible at this time. Determining whether prepubertal ovarian and testicular tissue cryopreservation should be
conducted requires an analysis of the four federal guidelines
discussed in Part II of this Article. Based upon potential medical
risks stated in Part IV, Section a of this Article, it is arguable that
ovarian and testicular tissue cryopreservation does not fit in the
category of research that is of minimal risk, as subjecting a child to
these risks seems greater than the risks a child would encounter in
daily life or during routine medical tests.98
If one considers these fertility preservation procedures as
research that involves greater than minimal risk, then the next
question is whether fertility preservation provides a direct benefit
to the child. According to the IOM, direct benefit means that there
is a “tangible positive outcome”; a likely conclusion from the
discussion in Part IV of this Article is that there is no “tangible
positive outcome,” there is only a mere possibility of a positive
outcome. As a result, ovarian and testicular tissue cryopreservation
would be subject to the additional requirements of Category 3
research. It is unclear whether pre-pubertal ovarian and testicular
tissue cryopreservation could withstand the Category 3
requirement; “[t]he intervention or procedures present experiences
to subjects that are reasonably commensurate with those inherent
in their actual or expected medical . . . situations.”99 Arguably, the
cryopreservation procedure is not something a child experiences
with their expected oncology care. Moreover, if one considers these
fertility preservation techniques to be outside the scope of
Categories 1, 2, and 3 of the federal regulations, then pre-pubertal
Procedures: Child Assent and Permission by Parents of Guardians,
http://ora.research.ucla.edu/OHRPP/Documents/Policy/9/ChildAssent_ParentPerm.
pdf (last updated June 9, 2016).
98. 45 C.F.R. § 46.102(i) (2016) (defining “[m]inimal risk”). Note, interpreting
the definition of minimal risk is controversial. D. B. Resnik, Eliminating the Daily
Life Risks Standard from the Definition of Minimal Risk, 31 J. MED. ETHICS 35, 35
(2005).
99. § 46.406(b).
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fertility cryopreservation is subject to significantly higher
standards. The research would have to alleviate “a serious problem
affecting the health or welfare of children” and the Secretary would
have to review the research.100 It is extremely unlikely that prepubertal fertility cryopreservation would meet this standard.
Determining whether these procedures follow appropriate
federal guidelines and determining what category, if any, they are
governed by greatly impacts whether these procedures should be
ongoing.
As mentioned earlier, Ravitsky et al. state that
experimental procedures that are greater than minimal risk and
that have no proven benefit should not be conducted without a
child’s assent.101 Conceivably, the IRBs at the University of
Pennsylvania and CHOP have concluded that ovarian and
testicular tissue cryopreservation is of minimal risk, or of greater
than minimal risk with a direct benefit to the child. However,
considering the lack of successful data and the minimal animal
trials, especially in the situation of testicular tissue removal,102 it is
imperative to question whether pre-pubertal ovarian and testicular
tissue cryopreservation should be conducted at this time, regardless
of assent.
V. Counter-Arguments in Favor of Pre-Pubertal Ovarian
and Testicular Tissue Cryopreservation Without Assent
This section of the Article will address the three most
compelling arguments in favor of pre-pubertal ovarian and
testicular tissue cryopreservation without assent:
(a) these
procedures will potentially preserve a child’s fertility; (b) parents
and guardians have a moral responsibility to safeguard an “open
future” for their children; and (c) these experimental procedures
should be conducted for the advancement of science.
a. Potentially Preserving Future Fertility
The most persuasive argument in favor of cryopreservation of
pre-pubertal ovarian or testicular tissue is that these procedures
may potentially preserve fertility for children who may become
infertile due to gonadotoxic treatment. Studies have shown that
individuals who have been treated for childhood cancers have an
increased risk of infertility.103 Male survivors rank testicular
100.
101.
102.
103.

§ 46.407.
PENN. CTR. FOR BIOETHICS, supra note 25, at 336.
Whiteman, supra note 22.
Denise Grady, Childhood Cancer Survivors Face Increased Risks Later, N.Y.
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dysfunction as one of the major side effects of oncology treatments,
while female survivors have experienced damage to their ovarian
tissue and uterine function.104 Determining the certainty of
infertility in these situations is unpredictable and difficult, as
infertility symptoms usually manifest much later in an individual’s
life. As a result, determining whether infertility is a direct result of
gonadotoxic treatments or other secondary factors such as age is
onerous and sometimes inconclusive.105
Moreover, oncology
treatments themselves vary and as a result will have different
gonadotoxic severities.106
Nonetheless, proponents of these
procedures argue that the increased risk of infertility is sufficient
reason to undertake these preventative measures. Additionally,
there have been successful pregnancies after re-transplantation of
ovarian tissue into women who have had their tissue cryopreserved,
and animal trials have shown success with re-transplantation of
testicular tissue.107
However, even though there is the potentiality of preserving
fertility by cryopreserving ovarian or testicular tissue, there are two
significant problems with this argument. First, there is no
guarantee that re-transplantation of ovarian or testicular tissue
later in life will result in fertility, as there are risks associated with
removal, cryopreservation, and re-transplantation.
Initially,
ovarian tissue cryopreservation had a low success rate because the
cryopreserving process damaged the tissue.108 Eventually a new
type of “freezing” called vitrification was developed in order to
prevent damaging crystallization.109 While vitrification proved
more successful, the exact number of how many women have been
re-implanted with their ovarian tissue remains unknown.110
Therefore, the success rate may actually be inconsequential
TIMES (Oct. 12, 2006), http://www.nytimes.com/2006/10/12/health/12chemo.html
?_r=0.
104. Sara E. Barton et al., Infertility, Infertility Treatment, and Achievement of
Pregnancy in Female Survivors of Childhood Cancer: A Report from the Childhood
Cancer Survivor Study Cohort, 14 LANCET ONCOLOGY 873, 873 (2013) (stating that
female cancer survivors “are less likely to become pregnant than . . . their siblings”);
Jill P. Ginsberg, New Advances in Fertility Preservation for Pediatric Cancer
Patients, 23 CURRENT OP. IN PEDIATRICS 9, 11–12 (2011); Louise E. Bath et al., Late
Effects of the Treatment of Childhood Cancer on the Female Reproductive System and
the Potential for Fertility Preservation, 109 BRITISH J. OF OBSTETRICS &
GYNAECOLOGY 107, 109 (2002).
105. Bath, supra note 104, at 107–108.
106. Id.
107. Wyns, supra note 17, at 316.
108. Quinn, supra note 94, at 2.
109. Wallace, supra note 91.
110. Id.
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compared to risking gonad and gametic tissue damage. Second,
refraining from cryopreserving ovarian or testicular tissue of
children undergoing gonadotoxic treatments does not necessitate
that these children will be infertile, as there are childhood cancer
survivors who become pregnant.111 In fact, some studies suggest
that while female cancer survivors may take longer to get pregnant
than sisters who have not had cancer, two-thirds of female cancer
survivors initially deemed infertile eventually became pregnant,
becoming so just took longer than their siblings.112 Furthermore,
“fertility cannot be assessed before puberty”; therefore, the effects
of oncology treatments are unclear.113 Lastly, this argument does
not take into account the potential of less invasive fertility
advancements that may be available in the future, nor does it
account for other options in creating a family, such as adoption or
the use of donor gametes.
b. Moral Responsibility to Give Children All Options
Parents and guardians have a moral and legal duty to act in
the best interest of their child. Defining what is considered to be in
the best interest of a child is extremely difficult, especially in the
area of medical decision-making. As a result, it is arguable that
parents and guardians of children experiencing gonadotoxic
treatments should, or are required to, cryopreserve their children’s
ovarian or testicular tissue as part of their duty as parents and
guardians. The argument in “bioethical literature [is coined] as a
‘right in trust,’ to be safeguarded until the child reaches
adulthood.”114 The argument originally stems from the bioethical
and philosophical concept of an “open future.”115 An “open future,”
originally posited by the academic Joel Feinberg, means that there
are a “set of moral rights children possess that are derived from the
autonomy rights of adults.”116 As a result, children have the right
to future fertility because as an adult they would have the capacity
to make the autonomous decision whether to procreate. Arguably,
111. Andrew Seaman, Pregnancy Possible for Many After Childhood Cancer,
REUTERS, July 15, 2013, http://www.reuters.com/article/us-pregnancy-possible-idUS
BRE96E0Q120130715.
112. Id.
113. Wyns, supra note 17, at 313.
114. Pascale Jadoul, Marie-Madeleine Dolmans & Jacques Donnez, Fertility
Preservation in Girls During Childhood: Is It Feasible, Efficient and Safe and to
Whom Should It Be Proposed?, 16 HUM. REPROD. UPDATE 617, 621 (2010).
115. Joseph Millum, The Foundation of the Child’s Right to an Open Future, 45 J.
SOC. PHIL. 522, 522 (2014).
116. Id.
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fertility is a component of normal human functioning, and as
Professor Norman Daniels would argue, “protecting normal
functioning contributes to protecting opportunity.”117
Thus,
proponents argue that even if a child cannot assent to the
procedure, it is the obligation of the parent or guardian to consent.
Furthermore, the extension of this argument is that parents could
be deemed irresponsible or neglectful if they do not provide this
option for children, because of the burden of potential infertility.118
While parents and guardians should provide opportunities
that are beneficial to their children, it is unconvincing to suggest
that they would be morally required to provide an experimental
medical treatment to their children. Additionally, if one follows this
argument in its entirety, why would ovarian and testicular tissue
cryopreservation be only limited to individuals who are
experiencing gonadotoxic treatment? There is an argument to be
made that if parents have an obligation to create and maintain an
“open future” for their children, they should provide fertility
preservation mechanisms at an early age because (1) there are
many causes of infertility that a child may face in their future, and
(2) if ovarian and testicular tissue cryopreservation happen while
the child is young, they will have no recollection of the procedures.
Most would agree that subjecting an otherwise healthy child to an
unnecessary medical procedure is ethically problematic.
Realistically, practical financial considerations or religious or
philosophical beliefs will prevent parents from permitting ovarian
and testicular tissue cryopreservation for their children who are
experiencing gonadotoxic treatments; therefore, the moral
responsibility argument is unconvincing.
c.

Advancement of Science as a Societal Imperative

As was mentioned earlier in this Article, the federal guidelines
may permit otherwise not-approvable human subject research
using children if it “presents an opportunity to understand, prevent,
or alleviate a serious problem affecting the health or welfare of
children.”119 There is an argument that even if cryopreservation of
a specific child’s gametic tissue were unsuccessful in being re-

117. Norman Daniels, Justice, Health, and Health Care, 1 AM. J. OF BIOETHICS 2,
3 (2001).
118. See Global Prevalence of Infertility, Infecundity and Childlessness, WHO,
http://www.who.int/reproductivehealth/topics/infertility/burden/en/ (last visited Oct.
8, 2017) (providing access to sources which outline the prevalence and impacts of
infertility).
119. 45 C.F.R. § 46.407 (2016); IRB GUIDEBOOK, supra note 31.
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transplanted, developing these fertility preservation techniques
assists in the advancement of science. Moreover, improving the
quality of life of cancer survivors is a beneficial social good. Unlike
adult-onset cancer, pediatric patients have approximately an eighty
percent long-term survivorship rate, which plausibly warrants
development of medical care for their future.120
However, as I argued before, it is unlikely that pre-pubertal
ovarian and testicular tissue cryopreservation will meet the
requirements for research in Category 4. A part of the requirement
for Category 4 research is that the IRB must “find[] that the
research presents a reasonable opportunity to further the
understanding, prevention, or alleviation of a serious problem
affecting the health or welfare of children.”121 It is unlikely to do so,
because while infertility is a serious medical concern, potential
infertility would not meet this threshold in consideration of the
potential medical risks children would undergo during this
research. Developing fertility preservation techniques for children
who experience gonadotoxic treatments is an ethically worthwhile
venture.
However, under a utilitarian ethical framework,
subjecting children, especially children who cannot assent, to
medically risky research that may not directly benefit them, simply
for the potential of preserving another child’s fertility, is ethically
impermissible.
Conclusion
While the intention of ovarian and testicular tissue
cryopreservation in pre-pubertal children is to benefit children
undergoing gonadotoxic treatments, it is ethically too problematic
to be permissible. The potential benefit of preserving fertility does
not outweigh the potential medical consequences and the conflicts
of interest, nor does it address potential future conflicts that will
result due to the cryopreserved material. Assent, while not
alleviating all concerns, will mitigate many of them. Moreover, the
federal guidelines and the AAP both highly encourage seeking
assent when conducting medical and experimental research on
children. Finally, the counter-arguments are unconvincing given
the potential risks to which children are exposed. As a result,
ovarian and testicular tissue cryopreservation in pre-pubertal
children without assent should not continue at this time.

120. Quinn, supra note 94, at 38.
121. § 46.407.

